5 results
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
to patients;
sales of the product may decrease significantly or the product could become less competitive; and
our reputation may suffer.
Any … demand for our products;
injury to our reputation and significant negative media attention;
withdrawal of clinical trial participants;
costs to defend
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
competitive; and
our reputation may suffer.
Any of these events could prevent us from achieving or maintaining market acceptance of the particular … or eventual outcome, liability claims may result in:
decreased demand for our products;
injury to our reputation and significant negative media attention
DRS
EX-10.1
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
by a Participant which the Company reasonably determines to be materially detrimental or damaging to the reputation, operations, prospects or business relations
DRS
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
to patients;
sales of the product may decrease significantly or the product could become less competitive; and
- 21 -
our reputation may suffer.
Any … in:
decreased demand for our products;
injury to our reputation and significant negative media attention;
withdrawal of clinical trial participants;
costs
- Prev
- 1
- Next